secwatch.observer — SEC 8-K summary
======================================

Issuer:     Point of Care Nano-Technology, Inc. (—)
CIK:        0001504239
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001199835-24-000220
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 5.01, 1.1, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PCNT acquires EZ Saliva diagnostic assets, issues 66M shares; control shifts to Dr. Guirguis
--------------------------------------------------------------------------------

- Acquired substantially all assets of Point of Care Nano-Technology, LLC, including EZ Saliva test kit IP and $101,400 cash, for 66M restricted shares.
- Dr. Raouf Guirguis became director and Chief Scientific Officer; his group obtained ~48.4% of outstanding common stock.
- Nathan Keele joined board with ~26.5% stake; previous controller Nicholas DeVito surrendered super-majority preferred for 5M common shares, remains CEO.
- Entered exclusive perpetual license with Zeus Diagnostics for oral-fluid patents in N.America; $35K upfront plus 7.5% royalty.
- Company to focus on commercializing EZ Saliva products; financial statements of acquired business to be filed by amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1504239/000119983524000220/0001199835-24-000220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1504239/000119983524000220/pcnt-8k.htm
  HTML page:      https://secwatch.observer/filing/0001199835-24-000220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer